Found GLP-1 Pricing: Insurance vs Cash-Pay Plans Compared for 2026

Last reviewed: September 4, 2026 Last updated: September 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Found operates two distinct pricing tracks: an insurance-supported plan and a standalone cash-pay subscription. The insurance track costs $199/month with monthly billing or $1,188 upfront for a 12-month prepaid plan ($99/month equivalent when paid annually). Compounded GLP-1 medication is included, but branded medications are billed separately and provider visits may require copays—typically around $30 per visit. The cash-pay track runs $289/month for compounded semaglutide or $359/month for tirzepatide with monthly billing; 12-month prepaid plans bring those effective rates down to $169/month and $239/month respectively, paid in full upfront. PlexusDx offers compounded semaglutide injection at $189/month with monthly billing or $149/month on a 6-month plan, and tirzepatide at $289/month monthly or $249/month on a 6-month plan—no membership fee, no insurance billing, no separate visit charges. All pricing verified September 4, 2026.

At-a-glance: Found insurance vs cash-pay vs PlexusDx

All figures verified September 4, 2026. Found's prepaid per-month rates are our calculation; 12-month totals assume monthly billing. Copay costs for Found's insurance track depend on visit frequency and individual plan coverage.

Breaking down Found's insurance track

Found's insurance-supported plan is designed for patients whose health coverage includes weight management services. The monthly billing rate is $199/month; a 12-month prepaid option lowers the effective monthly cost to $99 ($1,188 paid upfront). Compounded semaglutide or tirzepatide is included in the subscription price. Branded GLP-1 medications—Ozempic, Wegovy, Zepbound, Mounjaro—are billed separately through your insurance; out-of-pocket costs vary widely depending on formulary and prior authorization. Provider visits may require copays, typically around $30 per visit according to Found's published guidance, though visit frequency and total copay burden are not specified in the pricing materials.

Found states it has in-network clinicians for one in three Americans. If your insurance does not cover weight management visits or if you lack coverage entirely, the insurance track may not deliver meaningful savings over the cash-pay option—especially once copays and any out-of-network visit fees are added. The $99/month effective rate assumes you commit to and pay for the full 12-month period upfront; there is no month-to-month insurance rate below $199.

Found's cash-pay pricing and prepaid discounts

Found's cash-pay track bundles the provider visit, prescription, and compounded medication into a single subscription. Monthly billing is $289/month for compounded semaglutide or $359/month for compounded tirzepatide. Prepaid multi-month plans reduce the effective monthly rate: a 3-month plan for semaglutide costs $249/month (billed every 12 weeks), a 6-month plan costs $219/month, and a 12-month plan costs $169/month ($2,028 upfront). For tirzepatide, the 6-month plan is $289/month and the 12-month prepaid plan is $239/month ($2,868 upfront).

Found's billing cycle runs every four weeks, yielding 13 charges per year under monthly billing. Over 12 calendar months, compounded semaglutide on monthly billing totals $3,468; tirzepatide totals $4,308. The 12-month prepaid plans lock in lower per-month rates but require the full year's payment upfront and carry the opportunity cost of that capital.

Normalized 12-month cost comparison

Prepaid per-month equivalents are our calculation. Found's copay costs are visit-dependent and not included in these totals. PlexusDx billing runs on calendar months (12 charges per year); Found cash-pay runs every four weeks (13 charges per year for monthly billing).

What you get with each option

Both of Found's tracks include access to board-certified clinicians, a personalized care plan, the Found app with 24/7 care team access, and Aimee—Found's AI concierge for habit coaching and program navigation. The insurance track includes compounded GLP-1 medication in the subscription fee; branded medications (Ozempic, Wegovy, Zepbound, Mounjaro, Saxenda, Victoza) and orforglipron (Foundayo) are billed separately through your insurance. The cash-pay track includes compounded semaglutide or tirzepatide in the subscription price. Found offers a microdosing program and metformin as additional medication options. Both tracks are HSA- and FSA-eligible. Found provides a full refund if you are not clinically eligible and allows cancellation anytime through the app.

PlexusDx bundles the provider visit, prescription, compounded medication, and shipping into a single monthly price—no membership fee, no separate visit charges. The program includes a free Doctor of Pharmacy check-in and an optional genetics panel ($99 for program members, $298 standalone) that provides metabolic and carrier insights; the genetics test does not select or predict your medication, and your provider decides the prescription based on clinical assessment. PlexusDx bills on calendar months (12 charges per year) rather than every four weeks, and the same monthly rate applies at every dose throughout your titration and maintenance phases.

Insurance track vs cash-pay: decision factors

The value of Found's insurance track depends heavily on your coverage. If your plan includes in-network weight management visits and low or zero copays, the $99/month prepaid rate or $199/month standard rate may deliver savings—particularly if you pursue branded GLP-1 medications with favorable formulary placement. However, if your insurance does not cover weight management, imposes high copays, or if Found's clinicians are out-of-network for your plan, the insurance track may cost more than the cash-pay option once all fees are tallied. Found does not publish visit frequency or total expected copay costs, so it is difficult to model the true all-in expense without confirming your plan's specific coverage terms.

Found's cash-pay track offers pricing predictability: the monthly rate covers medication, visits, and app access with no variable copays or prior authorization delays. The 12-month prepaid plans ($169/month for semaglutide, $239/month for tirzepatide) require upfront payment of the full year but deliver the lowest per-month rate. If you prefer month-to-month flexibility or lack the capital for a large upfront payment, the monthly billing rates ($289 or $359) are higher than many competing cash-pay programs.

Month-to-month flexibility and commitment

PlexusDx's month-to-month semaglutide injection plan costs $189/month with no upfront commitment and no membership fee. That rate is $100/month lower than Found's cash-pay semaglutide monthly billing ($289) and $20/month higher than Found's 12-month prepaid effective rate ($169)—but PlexusDx requires no large upfront payment and bills 12 times per year rather than 13. Over 12 months, PlexusDx's month-to-month semaglutide plan totals $2,268; Found's monthly semaglutide totals $3,468. PlexusDx's 6-month semaglutide plan at $149/month totals $1,788 over a year, $240 less than Found's 12-month prepaid total of $2,028 and $600 less than Found's insurance track 12-month prepaid plan (before adding copays).

For tirzepatide, PlexusDx's month-to-month rate is $289—$70/month lower than Found's cash-pay monthly rate of $359 and matching Found's cash-pay monthly semaglutide rate exactly. PlexusDx's 6-month tirzepatide plan at $249/month totals $2,988 annually, $120 more than Found's 12-month prepaid tirzepatide rate of $2,868 but $1,320 less than Found's tirzepatide on monthly billing.

Service experience and platform ratings

Found holds a 4.1-star rating on Trustpilot from approximately 732 reviews (captured September 4, 2026). Positive themes center on the app's usability, responsive coaching, and the convenience of telehealth prescribing. Critical reviews cite delays in prescription fulfillment, difficulty reaching clinicians during high-volume periods, and frustration with insurance claim processing on the insurance track. Some reports describe out-of-pocket costs for branded medications exceeding initial expectations when prior authorization was denied or formulary tiers were higher than anticipated. These are individual reports; experiences vary by insurance plan, medication, and timing.

PlexusDx holds a 4.2-star rating on Trustpilot, with 76 percent of reviews at five stars and 81 percent at four stars or higher (captured September 4, 2026). The cash-only model eliminates insurance claim complexity, and the single monthly rate structure is frequently noted in positive reviews as reducing billing surprises.

Choose Found's insurance track if…

• Your health plan covers weight management visits in-network with low or zero copays and you have confirmed Found's clinicians participate in your network.
• You are pursuing a branded GLP-1 medication (Wegovy, Zepbound, Mounjaro) and your insurance formulary provides favorable coverage with manageable out-of-pocket costs.
• You can commit to and pay for the 12-month plan upfront ($1,188) to capture the $99/month effective rate.
• You value integrated app-based coaching and are willing to navigate insurance billing for medication separately from the program fee.

Choose Found's cash-pay track if…

• You lack insurance coverage for weight management or your plan imposes high copays and out-of-network fees.
• You want a single predictable monthly payment that includes compounded GLP-1 medication, visits, and app access.
• You have the capital to prepay 12 months ($2,028 for semaglutide, $2,868 for tirzepatide) and want the lowest effective monthly rate Found offers.
• You prefer Found's AI concierge, integrated habit coaching, and 24/7 care team access over a leaner clinical model.

Where PlexusDx fits

PlexusDx is a cash-only program that delivers compounded semaglutide or tirzepatide at lower month-to-month rates than Found's cash-pay monthly billing and with greater flexibility than Found's prepaid plans. The $189/month semaglutide rate and $289/month tirzepatide rate require no membership fee, no upfront commitment, and no separate visit charges. Billing runs on calendar months (12 charges per year), and the same rate applies at every dose. The 6-month plans ($149 semaglutide, $249 tirzepatide) offer additional savings without the capital requirement of a 12-month prepay. PlexusDx includes a free Doctor of Pharmacy check-in and an optional genetics panel for members interested in metabolic and carrier insights, though the genetics test does not select your medication—your provider makes that decision. If you want predictable monthly pricing, no insurance complexity, and the option to scale commitment as your response to treatment becomes clear, PlexusDx provides a straightforward cash-pay alternative.

Methodology and freshness

All Found pricing figures were captured from the provider's checkout flow and published pricing pages on September 4, 2026. PlexusDx pricing was verified against live product pages on the same date. Prepaid per-month equivalents (Found's $99, $169, and $239 rates) are our calculation, derived by dividing the upfront total by 12 months. The 12-month cost projections assume continuous monthly billing and are our calculation; individual results depend on plan selection, dose changes, and any early cancellation. Copay estimates for Found's insurance track reflect the provider's published guidance but actual visit costs vary by insurance plan and are not included in the annual totals shown. We do not model insurance claim outcomes, prior authorization success rates, or formulary tier placement for branded medications. Review ratings and volumes were captured from Trustpilot on September 4, 2026.

Frequently Asked Questions

Does Found's insurance track include the cost of GLP-1 medication?

Found's insurance track includes compounded semaglutide or tirzepatide in the subscription fee. Branded medications like Ozempic, Wegovy, Zepbound, and Mounjaro are billed separately through your insurance, and out-of-pocket costs depend on your formulary, prior authorization, and plan design.

Is Found's $99/month insurance rate available with monthly billing?

No. The $99/month rate is the effective monthly cost of a 12-month prepaid plan that requires $1,188 upfront. The standard monthly billing rate for Found's insurance track is $199/month. Both rates may carry additional copays for provider visits, typically around $30 per visit according to Found's guidance.

How does PlexusDx's month-to-month semaglutide cost compare to Found's cash-pay option?

PlexusDx's month-to-month semaglutide injection is $189/month with no membership fee and 12 billing cycles per year, totaling $2,268 annually. Found's cash-pay semaglutide on monthly billing is $289/month billed every four weeks (13 cycles), totaling $3,468 over 12 months—$1,200 more than PlexusDx.

Can I use HSA or FSA funds to pay for Found or PlexusDx?

Both Found and PlexusDx accept HSA and FSA payment for their programs. Confirm with your plan administrator that weight management services and compounded GLP-1 medications qualify under your specific account rules, as eligibility can vary by plan design and issuer.

What happens if I cancel a Found prepaid plan before the 12 months are up?

Found states you can cancel anytime through the app and offers a full refund if you are not clinically eligible. The refund or prorated credit policy for voluntary cancellation after eligibility is confirmed is not detailed in the published pricing materials; confirm the terms at enrollment before committing to a prepaid plan.

Sources

• PlexusDx internal comparison page (verified pricing and plan structures for Found and PlexusDx, accessed July 20, 2026 and September 4, 2026)
• Found pricing page at joinFound.com (insurance and cash-pay rates, plan details, inclusions, accessed September 4, 2026)
• PlexusDx product pages for semaglutide injection, tirzepatide injection, semaglutide oral, tirzepatide oral, and microdose GLP-1 (live pricing, plan terms, accessed July 20, 2026 and September 4, 2026)
• Found FAQ and program details (medication list, clinician access, refund policy, accessed September 4, 2026)
• Found checkout flow verification (billing cadence, upfront totals, prepaid equivalents, accessed September 4, 2026)
• Trustpilot ratings for Found and PlexusDx (star ratings, review volumes, captured September 4, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.